{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:12:19Z","timestamp":1765887139379},"reference-count":11,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,11]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> The goal of this study was to assess the long-term benefits of managing severe spasticity by using continuous infusion of intrathecal baclofen delivered via an implantable pump.<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> Eighteen patients with severe spasticity of cerebral origin, who failed to respond adequately to more conservative treatments, have been treated with continuous infusion of intrathecal baclofen delivered via an implanted pump. Follow-up review of these patients has lasted between 12 months and 9 years. The patients have been assessed using a variety of tools. Seventeen have had a significant reduction in tone and all have benefited by a reduced need for nursing care or increased function or both.<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> Long-term continuous infusion of intrathecal baclofen delivered via an implantable pump offers an effective method for dealing with otherwise intractable spasticity.<\/jats:p>","DOI":"10.3171\/jns.1999.91.5.0733","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:20:08Z","timestamp":1242235208000},"page":"733-736","source":"Crossref","is-referenced-by-count":61,"title":["Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients"],"prefix":"10.3171","volume":"91","author":[{"given":"Barry","family":"Rawicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1001\/jama.1993.03510200081036","article-title":"Continuous intrathecal baclofen infusion for spasticity of cerebral origin.","volume":"270","author":"Albright","year":"1993"},{"key":"b2","series-title":"Australian Guide for Use of the Uniform Data Systems for Medical Rehabilitation. Version 4 (1993).","year":"1993"},{"key":"b3","series-title":"Practitioner","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis.","volume":"192","author":"Ashworth","year":"1964"},{"key":"b4","series-title":"Am J Phys Med Rehab","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/00002060-198806000-00004","article-title":"Management of spasticity.","volume":"67","author":"Katz","year":"1988"},{"key":"b5","series-title":"Phys Med Rehab Clin North Am","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1047-9651(18)30648-X","article-title":"Mechanisms, measurement and management of spastic hypertonia after head injury.","volume":"3","author":"Katz","year":"1992"},{"key":"b6","series-title":"Paraplegia","first-page":"48","article-title":"Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.","volume":"29","author":"Loubser","year":"1991"},{"key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3171\/jns.1997.87.3.0415","article-title":"Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report.","volume":"87","author":"Maythaler","year":"1997"},{"key":"b8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3171\/jns.1996.85.3.0452","article-title":"Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity.","volume":"85","author":"Ordia","year":"1996"},{"key":"b9","series-title":"Ann NY Acad Sci","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1749-6632.1988.tb31822.x","article-title":"Intrathecal baclofen for severe spasticity.","volume":"531","author":"Penn","year":"1988"},{"key":"b10","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3171\/jns.1992.77.2.0236","article-title":"Intrathecal baclofen for spasticity of spinal origin: seven years of experience.","volume":"77","author":"Penn","year":"1992"},{"key":"b11","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.410280407","article-title":"Treatment of spasticity with Botulinum toxin: a double-blind study.","volume":"28","author":"Snow","year":"1990"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/91\/5\/article-p733.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/91\/5\/article-p733.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/91\/5\/article-p733.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:46:28Z","timestamp":1679881588000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/91\/5\/article-p733.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":11,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/jns.1999.91.5.0733","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}